Cancer type | n | Male (%) | Age | Purpose of MSI test | Smoking | Drinking | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
n | % | mean SD | range | genetic counseling | companion diagnostics | n | % | n | % | ||
LS (AII)-related cancers | |||||||||||
 Colorectum | 466 | 283 | 61% | 62.4 ± 12.3 | 25–87 | 127 | 339 | 302 | 65% | 239 | 51% |
 Endometrium | 75 | 0 | 0% | 57.9 ± 10.5 | 35–81 | 31 | 44 | 20 | 27% | 14 | 19% |
 Small intestine | 15 | 9 | 60% | 68.6 ± 11.1 | 50–82 | 6 | 9 | 9 | 60% | 6 | 40% |
 Renal pelvic/ureter | 0 | 0 | ー | ー | ー | ー | ー | ー | ー | ー | ー |
Subtotal | 556 | 292 | 53% | 62.0 ± 12.1§1 | 25–87 | 164 | 392 | 331 | 60%#1 | 259 | 47%*1 |
LS (rB-AII)-related cancers | |||||||||||
 Pancreas | 162 | 86 | 53% | 65.9 ± 9.9 | 30–84 | 29 | 133 | 76 | 47% | 70 | 43% |
 Biliary tract | 64 | 40 | 63% | 66.3 ± 9.7 | 38–84 | 1 | 63 | 33 | 52% | 38 | 59% |
 Stomach | 36 | 22 | 61% | 64.6 ± 9.7 | 39–81 | 18 | 18 | 29 | 81% | 24 | 67% |
 Ovary | 24 | 0 | 0% | 57.9 ± 13.4 | 27–80 | 3 | 21 | 5 | 21% | 6 | 25% |
 Brain | 2 | 1 | 50% | 49.0 ± 4.2 | 46–52 | 2 | 0 | 1 | 50% | 0 | 0% |
Subtotal | 288 | 149 | 52% | 65.0 ± 10.4§2 | 27–84 | 53 | 235 | 144 | 50%#2 | 138 | 48%*2 |
Non-LS-related cancers | |||||||||||
 Uterine cervix | 34 | 0 | 0% | 53.9 ± 13.1 | 33–75 | 0 | 34 | 14 | 41% | 15 | 44% |
 Laryngopharyngus and esophagus | 30 | 24 | 80% | 66.7 ± 10.0 | 45–83 | 0 | 30 | 28 | 93% | 22 | 73% |
 Skin | 27 | 15 | 56% | 65.1 ± 12.7 | 34–87 | 0 | 27 | 17 | 63% | 10 | 37% |
 Neuroendocrine | 22 | 16 | 73% | 64.2 ± 9.2 | 47–79 | 0 | 22 | 16 | 73% | 16 | 73% |
 Thymus | 10 | 6 | 60% | 58.9 ± 12.8 | 35–72 | 0 | 10 | 5 | 50% | 6 | 60% |
 Breast | 7 | 0 | 0% | 51.4 ± 6.5 | 41–60 | 0 | 7 | 4 | 57% | 2 | 29% |
 Liver | 6 | 4 | 67% | 68.3 ± 7.4 | 60–81 | 0 | 6 | 4 | 67% | 3 | 50% |
 Others | 20 | 13 | 65% | 54.3 ± 18.0 | 13–83 | 5 | 15 | 13 | 65% | 15 | 75% |
Subtotal | 156 | 78 | 50% | 60.5 ± 13.4§3 | 13–87 | 5 | 151 | 101 | 65%#3 | 89 | 57%*3 |
Total | 1000 | 519 | 52% | 62.6 ± 12.0 | 13–87 | 222 | 778 | 576 | 58% | 486 | 49% |